The Effects of Insulin Detemir and Gliclazide-MR Treatments in Addition to Life-style Modification and Metformin Therapy on Endothelial Functions in Patients With Type 2 Diabetes : An Open-labelled Randomized Prospective Study
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2012
At a glance
- Drugs Gliclazide (Primary) ; Insulin detemir (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
- 13 Aug 2012 Actual end date (1 Jun 2012) added as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.